Can a memory drug break the grip of Anorexia's rigid habits?

NCT ID NCT06518941

First seen Aug 03, 2026 · Last updated Aug 04, 2026 · Updated 1 time

Summary

This trial tests whether donepezil, a medication used for memory, can help adults with anorexia nervosa weaken the strong habits that drive restrictive eating. Ten participants will receive the drug for up to 8 weeks while staying in an inpatient unit, with weekly check-ins to monitor side effects. Researchers will also measure changes in habit strength and food preferences to see if the approach is worth studying further.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
donepezil
What this could lead to
If donepezil proves tolerable and shows promise, it could offer a new medication to help people with anorexia nervosa break rigid eating habits and improve recovery.
What could go wrong
This is a very small, early-stage trial focused on feasibility and safety, not effectiveness. Donepezil may cause side effects, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANOREXIA NERVOSA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Anorexia anorexia nervosa Feeding and Eating Disorders Habits

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • New York State Psychiatric Institute

    New York, New York, 10032, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.